COVID-19 vaccine-induced guillain-barre syndrome
First case of severe acute respiratory syndrome coronavirus-2 was detected in Wuhan province of china. Within a year, the vaccine development process accelerated and emergency approval was rolled out for vaccines. Covishield, an adenovirus vector-based vaccine manufactured by Serum Institute of Indi...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Serija: | Journal of the Scientific Society |
| Teme: | |
| Online pristup: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2024;volume=51;issue=1;spage=105;epage=107;aulast=Sajan |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|